Correlation Between Vaxart and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Vaxart and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and Cue Biopharma, you can compare the effects of market volatilities on Vaxart and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and Cue Biopharma.
Diversification Opportunities for Vaxart and Cue Biopharma
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vaxart and Cue is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Vaxart i.e., Vaxart and Cue Biopharma go up and down completely randomly.
Pair Corralation between Vaxart and Cue Biopharma
Given the investment horizon of 90 days Vaxart Inc is expected to generate 0.85 times more return on investment than Cue Biopharma. However, Vaxart Inc is 1.18 times less risky than Cue Biopharma. It trades about 0.01 of its potential returns per unit of risk. Cue Biopharma is currently generating about 0.0 per unit of risk. If you would invest 105.00 in Vaxart Inc on September 2, 2024 and sell it today you would lose (45.00) from holding Vaxart Inc or give up 42.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaxart Inc vs. Cue Biopharma
Performance |
| Timeline |
| Vaxart Inc |
| Cue Biopharma |
Vaxart and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxart and Cue Biopharma
The main advantage of trading using opposite Vaxart and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.The idea behind Vaxart Inc and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |